Clinical Trial Update: Cannabidiol as a Treatment for Social Anxiety Disorder (R61) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cannabidiol for social anxiety disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: NYU Langone Health | Conditions: Social Anxiety Disorder | Phase 2 | Status: COMPLETED